AzTrials
AzTrials

ColonoscopyNCT04906317

The Effectiveness of Sedation and Analgesia in Colonoscopy Treatment of Colorectal Polyps

A study testing midazolam and dezocine and Propofol in people with Colonoscopy and Sedation and Analgesia, run by Sixth Affiliated Hospital, Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to evaluate the effectiveness of sedation and analgesia in the treament of colorectal polyps by colonoscopy. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Colonoscopy, Sedation and Analgesia
What is being tested?
midazolam and dezocine and Propofol
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
340 participants
Where
1 siteChina
Study dates
1 Dec 2020to 12 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Colonoscopy diagnosed as a colorectal polyp, the number of polyps is less than 5, and the size of single polyp is less than 2.0 cm
  • Age more than 18 years and less than 70 years

Who cannot join

  • Allergy to propofol, dezocine, midazolam or eggs
  • ASA class IV, short and tick neck, difficult intubation due to inability to open the mouth widely
  • Suspected of gastrointestinal perforation, bleeding or obstruction
  • Acute gastrointestinal infection period
  • History of abdominal surgery
  • Patients during pregnancy or lactation

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • The Six Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510655

    Jiancong Hu, MD, +86 02038476875, hujianc@mail.sysu.edu.cn

    Recruiting

Other trials in China

About this study

Official title: The Effectiveness of Sedation and Analgesia in Colonoscopy Treatment of Colorectal Polyps: a Single-center, Prospective, Randomized Controlled Study

This study aims to evaluate the effectiveness of sedation and analgesia in the treament of colorectal polyps by colonoscopy.

Read the detailed description

Colorectal polyps are precancerous lesions of the colorectal cancer. Colonoscopy can reduce the risk of colorectal cancer. Painless endoscopy could reduce patient discomfort and improves the acceptance of treatment, especially for the endoscopic treatment of colorectal polyps. Intravenous anesthesia colonoscopy has a strong sedative effect and has obvious inhibitory effects on the respiratory and circulatory systems. It requires the assistance of an anesthesiologist. The lack of anesthesiologists makes it difficult to make an appointment for anesthesia colonoscopy, which is a bottleneck in the diagnosis and treatment of gastrointestinal diseases in China. Therefore, there is an urgent need to find a painless diagnosis and treatment method that is not inferior to anesthesia colonoscopy in comfort to meet the needs of patients. Comparing to anesthesia colonoscopy, sedative and analgesic colonoscopy have similar sedative and analgesic effects and do not require the assistance of an anesthesiologist. However, there is no relevant evaluation on the effectiveness of sedation and analgesia during the endoscopic treatment of colorectal polyps. Our department has used midazolam combined with dezocine to treat 185 patients with colorectal polyps in these years. Retrospective analysis showed that the sedative and analgesic effect is satisfactory. Therefore, it is necessary to make a single-center randomized parallel group controlled non-inferiority study to directly compare the effectiveness of sedation and analgesia versus intravenous anesthesia in endoscopic treatment of colorectal polyps.

Being tested
midazolam and dezocine, Propofol
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • midazolam and dezocineDrug

    Also called Not necessary

    Midazolam (0.05 mg/kg) and dezocine(5mg) sedation during colonoscopy, targeted to a painless level

  • PropofolDrug

    Also called Not necessary

    standard propofol (1.5mg/kg) induction during colonoscopy, targeted to a moderate sedation level

Study groups in NCT04906317
Study groupRoleWhat they receive
Sedation and AnalgesiaActive comparator0.05 mg/kg midazolam and 5mg dezocine iv infusion
Receives: Drug: midazolam and dezocine
AnesthesiaActive comparatorcontinuous 1.5mg/kg propofol iv infusion
Receives: Drug: Propofol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The score of visual analogue scoring (VAS)

    Assess immediately after the completement of colonoscopy

    Measured: immediately after the procedure of colonoscopy

Secondary outcomes (1)
  1. Treatment fee

    The fee of treatment refers to the total cost of anesthesia fee, anesthesia/sedation drug fee, intraoperative monitoring fee, endoscopy fee and endoscopic treatment fee

    Measured: During the colonoscopy procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2021
  2. Study start1 Dec 2020
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion12 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
340 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04906317
Sponsor's protocol ID
2021ZSLYEC-028
Status last verified
May 2021
First submitted
25 May 2021
Last updated
28 May 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing midazolam and dezocine and Propofol in people with Colonoscopy and Sedation and Analgesia, run by Sixth Affiliated Hospital, Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jiancong Hu, MD (+86 02038476875, hujianc@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The score of visual analogue scoring (VAS) (time frame: immediately after the procedure of colonoscopy). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in